Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP401495.RAWfKuMWOt9PuDSu5yNvmH4NnTK2p0BxZUxV_TR-VqQTM130_assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401495.RAWfKuMWOt9PuDSu5yNvmH4NnTK2p0BxZUxV_TR-VqQTM130_provenance.
• NP690020.RAapwgEwF8UVzucE2BdjJTh-L5R8sK6fisrNZEQ7boHyg130_assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690020.RAapwgEwF8UVzucE2BdjJTh-L5R8sK6fisrNZEQ7boHyg130_provenance.
• assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP921943.RAVGs34jMZhaSrRY7r8BT3K2aaOmNj1uBq55j6h6uaH_E130_assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921943.RAVGs34jMZhaSrRY7r8BT3K2aaOmNj1uBq55j6h6uaH_E130_provenance.
• NP317693.RAVrGzqU8_8BF7_9UXRmc2ZzpzO_fTBs5-x2HL7oTmJ8E130_assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317693.RAVrGzqU8_8BF7_9UXRmc2ZzpzO_fTBs5-x2HL7oTmJ8E130_provenance.
• assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP317888.RAjkoycevMPMJk4gfbAr4FY5F5b_3C7nsDeaXBkgN-07U130_assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317888.RAjkoycevMPMJk4gfbAr4FY5F5b_3C7nsDeaXBkgN-07U130_provenance.
• NP852019.RAeo6Z3zAzik_dk3hQ2Fm6OKYKSgD6UE2JHoawgkaAnSg130_assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852019.RAeo6Z3zAzik_dk3hQ2Fm6OKYKSgD6UE2JHoawgkaAnSg130_provenance.
• NP921931.RAt8-mVcnnm5u6GqynHZM2NvH5M21eslGMqxVqtRcHOig130_assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921931.RAt8-mVcnnm5u6GqynHZM2NvH5M21eslGMqxVqtRcHOig130_provenance.
• NP1000678.RAk-8J_UifY-JVG86EBEVXRYhXCS8bHVAwc3bJDtgpXZ4130_assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1000678.RAk-8J_UifY-JVG86EBEVXRYhXCS8bHVAwc3bJDtgpXZ4130_provenance.
• NP1000690.RAvuDQgNtAFEVbP5NVH51wKTx1sRYg6XO-CG4M-Jgotbw130_assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1000690.RAvuDQgNtAFEVbP5NVH51wKTx1sRYg6XO-CG4M-Jgotbw130_provenance.
• NP852015.RAvWt02IwVLtytDvYMPlAbtTR1L8hwJcRTcQzsuVBQRY8130_assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852015.RAvWt02IwVLtytDvYMPlAbtTR1L8hwJcRTcQzsuVBQRY8130_provenance.
• NP852017.RA1EHcxpt2ze62FhvgOAUBy6SusE39SUxQgHa4TPQoNEw130_assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852017.RA1EHcxpt2ze62FhvgOAUBy6SusE39SUxQgHa4TPQoNEw130_provenance.
• NP852021.RA8Sslsv3ybHjpUgu35jP5hv87NK1Kus9wP1PB-U-O8iI130_assertion description "[Our findings suggest that hBD3 represents a novel NF-?B-regulated mediator of CCR7 expression and anti-apoptotic pathways, which may be exploited by developing SCCHN tumors to enhance their survival and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852021.RA8Sslsv3ybHjpUgu35jP5hv87NK1Kus9wP1PB-U-O8iI130_provenance.